What variants in your NGS data really matter?

Introducing the VAA Suite for analyzing, annotating, and filtering variants. Learn how you can pinpoint the variants most relevant to your research.

Get Started

Solutions for Next-Generation Medicine

From the Appistry Knowledge Center


Appistry Appoints Rare Disease Expert Cornelius Boerkoel as Chief Medical Officer

Newly created medical officer role extends Appistry’s management footprint to span research and clinical genomics. ST LOUIS, MO (October 17, 2014) – Appistry, Inc., a leading provider of tools, software, […]


Live Webinar: Three Strategies for Starting Up An NGS Lab

Case studies and live demonstrations will help you learn the three strategies your lab needs to be successful with NGS analysis, but may need help doing.


Appistry Awards Inaugural Pipeline Challenge Prize to the Shivanand R. Patil Cytogenetics and Molecular Laboratory

Proposed next-generation sequencing (NGS) quality control pipeline will reduce costs and lower turnaround times for common genomics tests ST. LOUIS, MO (October 6, 2014) – Appistry, Inc., a leading provider of […]


Introducing Appistry’s Variant Annotation and Analysis Suite

The real challenge in NGS analysis is identifying the causal variants that may be associated with disease. Learn how Appistry is streamlining this process with an integrated suite of post-processing […]


Comparison of Haplotype Caller Performance Using Joint Discovery and Reference Confidence Modes

This application note compares the performance of the joint discovery mode used in GATK 2 with the reference confidence model for incremental joint discovery introduced by the Broad Institute with […]


The Impact of Different Sample Types and Filtering Modes on MuTect’s Variant Calling Performance

This application note explores MuTect’s variant calling ability when processing three different sample types: a matched tumor/normal pair, a tumor-only sample, and a tumor sample with an unmatched normal. MuTect […]